The ISPOR Latin America Consortium Health Technology Producers (Industry) provides a platform for industry members to discuss issues important to health technology assessment, healthcare system development, and patient access to innovation in the region.The committee has four workstreams:
- Value of Health Technologies
- Real World Evidence
Consortium members may participate in working groups. If you are interested in more information or in collaborating, please contact us.
Homero Monsanto, MS, RPh, BS, PhD
Claudia Soares, PhD, MD, MPH
- The Usage of RWE in Monitoring and Managing Health Technologies in Latin America - What We Learned and Where We are Heading, held on 10 August 2021
- MCDA - How to Guide Through the Application of Different Methods for Assessment and Prioritization of Rare Disease Health Technologies, held on 04 April 2019
- The Use of MCDA for HTA Agencies – Options, Limitations and the Way Forward, held on 03 April 2019
Archived Committee Products:
Webinar Presentation: "The Use of Multiple Criteria Decision Analysis for Health Technology Assessment Agencies: Options, Limitations and the Way Forward"
Presented: April 3, 2019
Presenter: Rob Baltussen, PhD, Radboud University Medical Center, The Netherlands
Webinar Presentation: "MCDA: How to Guide Through the Application of Different Methods for Assessment and Prioritization of Rare Disease Health Technologies"
Presented: April 4, 2019
Presenter: Vladimir Zah, DPhil, ACIM, CPIAPD, Rx Outcomes Research Inc, Canada
Webinar Presentation: MCDA Application to Oncology
Presented: November 27, 2018
Presenter: Panagiotis Orfanos, MPhil, MSc
F. Hoffmann-La Roche Ltd, Switzerland